Active specific immunotherapy with the 1E10 anti-idiotype vaccine in the treatment of patients with small-cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Racotumomab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
- 13 Sep 2011 New trial record